Core Viewpoint - The stock of Steady Medical (300888) has shown a positive performance with a closing price of 42.36 yuan, reflecting a 1.17% increase as of August 29, 2025, despite a net outflow of main funds [1][2]. Financial Performance - Steady Medical reported a main revenue of 5.296 billion yuan for the first half of 2025, representing a year-on-year increase of 31.31% [3]. - The net profit attributable to shareholders was 492 million yuan, up 28.07% year-on-year, while the net profit after deducting non-recurring gains and losses was 461 million yuan, increasing by 40.9% [3]. - In Q2 2025, the company achieved a single-quarter main revenue of 2.691 billion yuan, a 26.66% increase year-on-year, and a net profit of 243 million yuan, up 20.68% [3]. Market Position - Steady Medical's total market capitalization is 24.667 billion yuan, ranking 4th in the beauty and personal care industry [3]. - The company has a net asset of 12.276 billion yuan, ranking 1st in the industry, and a net profit of 492 million yuan, ranking 3rd [3]. - The company's price-to-earnings ratio (P/E) is 25.07, which is lower than the industry average of 31.93, ranking 3rd [3]. Fund Flow Analysis - On August 29, 2025, the main funds experienced a net outflow of 47.5893 million yuan, accounting for 6.42% of the total transaction amount [1][2]. - Retail investors showed a net inflow of 48.1353 million yuan, representing 6.49% of the total transaction amount on the same day [1][2]. - Over the past five days, the stock has seen fluctuations in fund flows, with varying levels of net inflows and outflows from main and retail investors [2]. Institutional Ratings - In the last 90 days, 20 institutions have rated the stock, with 17 buy ratings and 3 hold ratings [4]. - The average target price set by institutions over the past 90 days is 55.82 yuan [4].

Core Viewpoint - The stock of Steady Medical (300888) has shown a positive performance with a closing price of 41.87 yuan, reflecting a 2.25% increase on August 28, 2025, amidst varying capital flows from different investor groups [1][2]. Financial Performance - For the first half of 2025, Steady Medical reported a main revenue of 5.296 billion yuan, representing a year-on-year increase of 31.31% - The net profit attributable to shareholders was 492 million yuan, up 28.07% year-on-year - The net profit after deducting non-recurring gains and losses was 461 million yuan, marking a 40.9% increase year-on-year - In Q2 2025, the company achieved a single-quarter main revenue of 2.691 billion yuan, a 26.66% increase year-on-year, and a net profit of 243 million yuan, up 20.68% year-on-year [3]. Market Position - Steady Medical's total market capitalization stands at 24.382 billion yuan, significantly higher than the industry average of 11.443 billion yuan, ranking 4th in the industry - The company has a net asset value of 12.276 billion yuan, leading the industry with a ranking of 1st - The company's net profit of 492 million yuan ranks 3rd in the industry, while its price-to-earnings ratio (24.78) and price-to-book ratio (2.12) rank 4th and 5th respectively [3]. Investor Sentiment - Over the past 90 days, 19 institutions have rated the stock, with 16 buy ratings and 3 hold ratings - The average target price set by institutions for the stock is 55.82 yuan [4].

Group 1 - The stock of Steady Medical (300888) closed at 41.89 yuan on August 20, 2025, with an increase of 1.48% and a turnover rate of 4.54% [1] - The net inflow of main funds was 14.12 million yuan, accounting for 4.25% of the total transaction amount, while retail investors experienced a net outflow of 6.98 million yuan, representing 2.1% of the total [1][2] - Over the past five days, the stock has seen fluctuations in fund flows, with significant net outflows from retail investors on several days [2] Group 2 - Steady Medical's total market value is 24.39 billion yuan, with a net asset of 12.15 billion yuan, and a net profit of 249 million yuan, ranking 4th, 1st, and 3rd respectively in the beauty and personal care industry [3] - The company's main revenue for Q1 2025 was 2.61 billion yuan, a year-on-year increase of 36.47%, and the net profit attributable to shareholders was 249 million yuan, also up 36.26% year-on-year [3] - The company's gross profit margin stands at 48.46%, which is higher than the industry average of 42.27% [3] Group 3 - In the last 90 days, 15 institutions have rated the stock, with 13 buy ratings and 2 hold ratings, and the average target price set by institutions is 59.1 yuan [4]

证券之星消息，截至2025年8月18日收盘，稳健医疗(300888)报收于41.42元，上涨1.4%，换手率 5.16%，成交量9.05万手，成交额3.74亿元。 8月18日的资金流向数据方面，主力资金净流出2253.21万元，占总成交额6.02%，游资资金净流出 1706.28万元，占总成交额4.56%，散户资金净流入3959.5万元，占总成交额10.58%。 近5日资金流向一览见下表： | 指标 | 稳健医疗 | 美容护理行业均值 | 行业排名 | | --- | --- | --- | --- | | 总市值 | 241.2亿元 | 111.94亿元 | 4 28 | | 净资产 | 121.46亿元 | 33.63亿元 | 1 28 | | 净利润 | 2.49亿元 | 9516.51万元 | 3 28 | | 市盈率(动) | 24.26 | 40.26 | 4 28 | | 市净率 | 2.14 | 2.92 | 5 28 | | 毛利率 | 48.46% | 42.27% | 12 28 | | 净利率 | 10.05% | 8.48% | 11 28 | | ROE | 2.13% | 2.4 ...

Group 1 - The stock of Steady Medical (300888) closed at 40.85 yuan on August 15, 2025, with an increase of 1.44% and a turnover rate of 3.75% [1] - The net outflow of main funds was 20.47 million yuan, accounting for 7.65% of the total turnover, while retail investors had a net inflow of 34.56 million yuan, representing 12.92% of the total turnover [1][2] Group 2 - Over the past five days, the stock experienced fluctuations, with a peak closing price of 41.08 yuan on August 13, 2025, and a low of 40.27 yuan on August 14, 2025 [2] - The company reported a total market value of 23.788 billion yuan, with a net profit of 249 million yuan, reflecting a year-on-year increase of 36.26% [3] - The company's gross profit margin stood at 48.46%, which is higher than the industry average of 42.27% [3] Group 3 - In the last 90 days, 15 institutions provided ratings for the stock, with 13 buy ratings and 2 hold ratings, and the average target price set at 59.1 yuan [4]

证券之星消息，截至2025年8月13日收盘，稳健医疗(300888)报收于41.08元，上涨0.37%，换手率 5.42%，成交量9.52万手，成交额3.9亿元。 8月13日的资金流向数据方面，主力资金净流出3440.39万元，占总成交额8.81%，游资资金净流出636.8 万元，占总成交额1.63%，散户资金净流入4077.19万元，占总成交额10.44%。 稳健医疗2025年一季报显示，公司主营收入26.05亿元，同比上升36.47%；归母净利润2.49亿元，同比 上升36.26%；扣非净利润2.34亿元，同比上升62.46%；负债率31.72%，投资收益459.1万元，财务费用 16.14万元，毛利率48.46%。稳健医疗（300888）主营业务：棉类制品的研发、生产、销售,覆盖医疗卫 生、个人护理、家庭护理、母婴护理、家纺服饰等。 该股最近90天内共有16家机构给出评级，买入评级13家，增持评级3家；过去90天内机构目标均价为 57.38。 资金流向名词解释：指通过价格变化反推资金流向。股价处于上升状态时主动性买单形成的成交额是推 动股价上涨的力量，这部分成交额被定义为资金流入，股价处于下跌状态时主动 ...

证券之星消息，截至2025年8月11日收盘，稳健医疗(300888)报收于40.5元，下跌0.07%，换手率3.9%， 成交量6.85万手，成交额2.77亿元。 8月11日的资金流向数据方面，主力资金净流出2193.67万元，占总成交额7.93%，游资资金净流出 286.07万元，占总成交额1.03%，散户资金净流入2479.74万元，占总成交额8.96%。 近5日资金流向一览见下表： 稳健医疗2025年一季报显示，公司主营收入26.05亿元，同比上升36.47%；归母净利润2.49亿元，同比 上升36.26%；扣非净利润2.34亿元，同比上升62.46%；负债率31.72%，投资收益459.1万元，财务费用 16.14万元，毛利率48.46%。稳健医疗（300888）主营业务：棉类制品的研发、生产、销售,覆盖医疗卫 生、个人护理、家庭护理、母婴护理、家纺服饰等。 该股最近90天内共有16家机构给出评级，买入评级13家，增持评级3家；过去90天内机构目标均价为 57.38。 资金流向名词解释：指通过价格变化反推资金流向。股价处于上升状态时主动性买单形成的成交额是推 动股价上涨的力量，这部分成交额被定义为资金流 ...

证券之星消息，截至2025年8月1日收盘，稳健医疗(300888)报收于40.11元，上涨0.28%，换手率 2.63%，成交量4.62万手，成交额1.86亿元。 8月1日的资金流向数据方面，主力资金净流入61.17万元，占总成交额0.33%，游资资金净流入1979.65 万元，占总成交额10.67%，散户资金净流出2040.82万元，占总成交额11.0%。 | 指标 | 稳健医疗 | 美容护理行业均值 | 行业排名 | | --- | --- | --- | --- | | 总市值 | 233.57亿元 | 108.44亿元 | 4 28 | | 净资产 | 121.46亿元 | 33.8亿元 | 1 28 | | 净利润 | 2.49亿元 | 7564.78万元 | 3 28 | | 市盈率(动) | 23.49 | 39.93 | 6 28 | | 市净率 | 2.07 | 2.84 | 5 28 | | 毛利率 | 48.46% | 42.27% | 12 28 | | 净利率 | 10.05% | 8.7% | 11 28 | | ROE | 2.13% | 1.91% | 10 28 | 稳健医疗 ...

证券之星消息，截至2025年7月31日收盘，稳健医疗(300888)报收于40.0元，下跌2.32%，换手率 3.82%，成交量6.7万手，成交额2.7亿元。 7月31日的资金流向数据方面，主力资金净流出2742.98万元，占总成交额10.15%，游资资金净流入 1991.51万元，占总成交额7.37%，散户资金净流入751.46万元，占总成交额2.78%。 近5日资金流向一览见下表： | | | | | 日期 收盘价 涨跌幅 主力净流入 主力净占比 游资净点比 散户净流入 散户净占比 | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 2025-07-31 | 40.00 | -2.32% | -2742.98万 | -10.15% | 1991.51万 | 7.37% | 751.46万 | 2.78% | | 2025-07-30 | | 40.95 0.32% | -1000.71万 | -3.11% | 61.69万 | 0.19% | 939.02万 | 2.92% | | 2025-07-29 | | 40.82 ...